Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00205023
What this trial is testing

Disseminated Endometrial Cancer Cells During Sonohysterography

Who this might be right for
Endometrial Cancer
University of Wisconsin, Madison 25
Not applicableStudy completedNCT02676726
What this trial is testing

STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer

Who this might be right for
Endometrial NeoplasmsOvarian Neoplasms
Hospital Universitari Vall d'Hebron Research Institute 208
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Not applicableStudy completedNCT02465541
What this trial is testing

Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors

Who this might be right for
ObesityEndometrial Carcinoma
Ohio State University Comprehensive Cancer Center 16
Early research (Phase 1)WithdrawnNCT06681870
What this trial is testing

ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors

Who this might be right for
CLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more
Astellas Pharma Global Development, Inc.
Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Not applicableEnded earlyNCT01271959
What this trial is testing

ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Who this might be right for
Solid Organ Tumors
Precision Therapeutics 167
Not applicableUnknownNCT04787159
What this trial is testing

Endometrial Cancer International Database

Who this might be right for
Endometrial Cancer
Assiut University 1,000
Not applicableStudy completedNCT02096783
What this trial is testing

Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

Who this might be right for
Anxiety DisorderCervical CancerEndometrial Cancer+8 more
University of Wisconsin, Madison 15
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Large-scale testing (Phase 3)Looking for participantsNCT07022483
What this trial is testing

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Who this might be right for
Endometrial Cancer
Daiichi Sankyo 710
Testing effectiveness (Phase 2)Study completedNCT00513786
What this trial is testing

Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
David O'Malley 38
Not applicableLooking for participantsNCT06656949
What this trial is testing

Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer

Who this might be right for
Endometrial Cancer
Qilu Hospital of Shandong University 42
Testing effectiveness (Phase 2)Looking for participantsNCT07594015
What this trial is testing

Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance

Who this might be right for
Recurrent Endometrial Cancer
University of Miami 46
Not applicableStudy completedNCT03898947
What this trial is testing

Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies

Who this might be right for
Breast CancerEndometrial Cancer
Università degli Studi dell'Insubria 1,329
Not applicableLooking for participantsNCT05179447
What this trial is testing

PROfiling Based Endometrial Cancer Adjuvant Therapy

Who this might be right for
Endometrial Cancer Stage IEndometrial Cancer Stage II
Women's Hospital School Of Medicine Zhejiang University 590
Testing effectiveness (Phase 2)Looking for participantsNCT05768139
What this trial is testing

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Who this might be right for
Breast CancerSolid Tumors, Adult
Eli Lilly and Company 880
Not applicableLooking for participantsNCT07675967
What this trial is testing

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Who this might be right for
Lung Cancer (Diagnosis)OsteochondromaSpitz Nevus+14 more
Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07737795
What this trial is testing

Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer

Who this might be right for
Endometrial Cancer
University of Oklahoma 66
Next Page